UK markets close in 37 minutes

Coloplast A/S (COLO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
860.20+19.00 (+2.26%)
As of 04:53PM CEST. Market open.
Currency in DKK

Valuation measures4

Market cap (intra-day) 189.12B
Enterprise value 209.84B
Trailing P/E 37.76
Forward P/E 34.72
PEG ratio (5-yr expected) 3.22
Price/sales (ttm)7.30
Price/book (mrq)12.50
Enterprise value/revenue 8.39
Enterprise value/EBITDA 26.37

Trading information

Stock price history

Beta (5Y monthly) 0.30
52-week change 3-14.16%
S&P500 52-week change 322.43%
52-week high 3991.80
52-week low 3689.20
50-day moving average 3917.26
200-day moving average 3813.87

Share statistics

Avg vol (3-month) 3236.94k
Avg vol (10-day) 3223.2k
Shares outstanding 5206.82M
Implied shares outstanding 6224.82M
Float 8141.83M
% held by insiders 135.00%
% held by institutions 129.81%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 421
Forward annual dividend yield 42.50%
Trailing annual dividend rate 321.00
Trailing annual dividend yield 32.50%
5-year average dividend yield 42.06
Payout ratio 494.25%
Dividend date 3N/A
Ex-dividend date 408 Dec 2023
Last split factor 25:1
Last split date 319 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 19.47%
Operating margin (ttm)27.60%

Management effectiveness

Return on assets (ttm)10.29%
Return on equity (ttm)46.30%

Income statement

Revenue (ttm)25B
Revenue per share (ttm)115.25
Quarterly revenue growth (yoy)8.20%
Gross profit (ttm)N/A
EBITDA 7.66B
Net income avi to common (ttm)4.87B
Diluted EPS (ttm)22.29
Quarterly earnings growth (yoy)7.50%

Balance sheet

Total cash (mrq)916M
Total cash per share (mrq)4.08
Total debt (mrq)21.63B
Total debt/equity (mrq)143.01%
Current ratio (mrq)0.53
Book value per share (mrq)67.33

Cash flow statement

Operating cash flow (ttm)5.53B
Levered free cash flow (ttm)7.24B